Association among dietary flavonoids, flavonoid subclasses and ovarian cancer risk: A meta-analysis

PLoS ONE

Volumn 11, Issue 3, 2016, Pages

  Hua, Xiaoli ^a   Yu, Lili ^a   You, Ruxu ^a   Yang, Yu ^a   Liao, Jing ^a   Chen, Dongsheng ^a   Yu, Lixiu ^a  

^a HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

FLAVONOID; FLAVONOL DERIVATIVE; ISOFLAVONE DERIVATIVE;

ARTICLE; CANCER INCIDENCE; CANCER PREVENTION; CANCER RISK; COHORT ANALYSIS; DIETARY INTAKE; DISEASE ASSOCIATION; HUMAN; OVARY CANCER; RISK REDUCTION; SENSITIVITY ANALYSIS; ANIMAL; DIET; FEMALE; META ANALYSIS; METABOLISM; OVARIAN NEOPLASMS; RISK FACTOR;

ANIMALS; DIET; FEMALE; FLAVONOIDS; HUMANS; OVARIAN NEOPLASMS; RISK FACTORS;

EID: 84961221100     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0151134     Document Type: Article

References (47)

1. Siegel R, Ma J, Zou Z, Jemal A.Cancer statistics, 2014. CA Cancer J Clin. 2014; 64: 9-29. doi: 10.3322/caac.21208 PMID: 24399786
2. Ferlay J, Soerjomataram I, Dikshit R, Eser S, Mathers C, Rebelo M, Parkin DM, Forman D, Bray F. Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer. 2015; 136: E359-386. doi: 10.1002/ijc.29210 PMID: 25220842
3. American Cancer Society. Cancer Facts and Figures 2013. Atlanta American Cancer Society; 2013.
4. Pesec M, Sherertz T.Global health from a cancer care perspective. Future Oncol. 2015; 11: 2235-2245. doi: 10.2217/fon.15.142 PMID: 26235185
5. D'Archivio M, Filesi C, Di Benedetto R, Gargiulo R, Giovannini C, Masella R. Polyphenols, dietary sources and bioavailability.Ann Ist Super Sanita. 2007; 43: 348-361. PMID: 18209268
6. Corcoran MP, McKay DL, Blumberg JB. Flavonoid basics: chemistry, sources, mechanisms of action, and safety.J Nutr Gerontol Geriatr. 2012; 31:176-189. doi: 10.1080/21551197.2012.698219 PMID: 22888837
7. Ross JA, Kasum CM. Dietary flavonoids: bioavailability, metabolic effects, and safety. Annu Rev Nutr. 2002; 22: 19-34. PMID: 12055336
8. Kim MK, Kim JH, Nam SJ, Ryu S, Kong G. Dietary intake of soy protein and tofu in association with breast cancer risk based on a case-control study.Nutr Cancer. 2008; 60: 568-576. doi: 10.1080/ 01635580801966203 PMID: 18791919
9. Hui C, Qi X, Qianyong Z, Xiaoli P, Jundong Z, Mantian M. Flavonoids, flavonoid subclasses and breast cancer risk: a meta-analysis of epidemiologic studies. PLoS One. 2013; 8: e54318. doi: 10.1371/ journal.pone.0054318 PMID: 23349849
10. Aune D, Lau R, Chan DS, Vieira R, Greenwood DC, Kampman E, Norat T.Nonlinear reduction in risk for colorectal cancer by fruit and vegetable intake based on meta-analysis of prospective studies. Gastroenterology. 2011; 141: 106-118. doi: 10.1053/j.gastro.2011.04.013 PMID: 21600207
11. Tang NP, Zhou B, Wang B, Yu RB, Ma J. Flavonoids intake and risk of lung cancer: a meta-analysis. Jpn J Clin Oncol. 2009; 39: 352-359. doi: 10.1093/jjco/hyp028 PMID: 19351659
12. Cassidy A, Huang T, Rice MS, Rimm EB, Tworoger SS.Intake of dietary flavonoids and risk of epithelial ovarian cancer.Am J Clin Nutr. 2014; 100:1344-1351. doi: 10.3945/ajcn.114.088708 PMID: 25332332
13. Kelly E. H., Anthony R. T., Dennis J. B.. Flavonoid antioxidants: chemistry, metabolism and structureactivity relationships. Journal of Nutritional Biochemistry, 2002, 13: 572-584. PMID: 12550068
14. U.S. Department of Agriculture. Iowa State University database on the isoflavone content of foods, Release 1.3. Beltsville, MD: USDA, 2002.
15. U.S. Department of Agriculture. USDA database for the flavonoid content of selected foods. Beltsville, MD: USDA, 2003.
16. McCann SE, Freudenheim JL, Marshall JR, Graham S. Risk of human ovarian cancer is related to dietary intake of selected nutrients, phytochemicals and food groups. J Nutr. 2003; 133: 1937-1942. PMID: 12771342
17. Zhang M, Xie X, Lee AH, Binns CW. Soy and isoflavone intake are associated with reduced risk of ovarian cancer in southeast china. Nutr Cancer. 2004; 49:125-130. PMID: 15489204
18. Chang ET, Lee VS, Canchola AJ, Clarke CA, Purdie DM, Reynolds P, et al. Diet and risk of ovarian cancer in the California Teachers Study cohort. Am J Epidemiol. 2007; 165: 802-813. PMID: 17210953
19. Gates MA, Tworoger SS, Hecht JL, De Vivo I, Rosner B, Hankinson SE. A prospective study of dietary flavonoid intake and incidence of epithelial ovarian cancer. Int J Cancer. 2007; 121: 2225-2232. PMID: 17471564
20. Rossi M, Negri E, Lagiou P, Talamini R, Dal Maso L, Montella M, Franceschi S, La Vecchia C. Flavonoids and ovarian cancer risk: A case-control study in Italy. Int J Cancer. 2008; 123: 895-898. doi: 10.1002/ijc.23549 PMID: 18491402
21. Neergheen VS, Bahorun T, Taylor EW, Jen LS, Aruoma OI. Targeting specific cell signaling transduction pathways by dietary and medicinal phytochemicals in cancer chemoprevention. Toxicology. 2010; 278: 229-241. doi: 10.1016/j.tox.2009.10.010 PMID: 19850100
22. Lee KW, Bode AM, Dong Z. Molecular targets of phytochemicals for cancer prevention. Nat Rev Cancer. 2011; 11: 211-218. doi: 10.1038/nrc3017 PMID: 21326325
23. Vanden Berghe W.Epigenetic impact of dietary polyphenols in cancer chemoprevention: lifelong remodeling of our epigenomes. Pharmacol Res. 2012; 65:565-576. doi: 10.1016/j.phrs.2012.03.007 PMID: 22465217
24. Dan ping S. Xiaoping W, Liqiang Q. Isoflavones Intake and Risk of Ovarian Cancer: A Meta-Analysis of Epidemiological Study. Soybean Science. 2013; 32: 814-817.
25. Crane TE, Khulpateea BR, Alberts DS, Basen-Engquist K, Thomson CA. Dietary intake and ovarian cancer risk: a systematic review.Cancer Epidemiol Biomarkers Prev. 2014; 23: 255-273. doi: 10.1158/ 1055-9965.EPI-13-0515 PMID: 24142805
26. Stroup DF, Berlin JA, Morton SC, Olkin I, Williamson GD, Rennie D, et al. Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis Of Observational Studies in Epidemiology (MOOSE) group. JAMA: the journal of the American Medical Association. 2000; 283 (15):2008-2012. PMID: 10789670
27. Wells G, Shea B, O'Connell D, Peterson J, Welch V, Losos M, et al. The Newcastle-Ottawa scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses. Ottawa, ON: Ottawa Hospital Research Institute. Available: www.ohri.ca/programs/clinical-epidemiology/oxford.asp. Accessed 25 October 2011.
28. Higgins JPT and Green S (2011 Available from www.cochrane-handbook.org.) Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration.
29. Hardy RJ, Thompson SG. Detecting and describing heterogeneity in meta-analysis. Stat Med. 1998; 17: 841-856. PMID: 9595615
30. DerSimonian R, Laird N. Meta-analysis in clinical trials. Control Clin Trials. 1986; 7: 177-188. PMID: 3802833
31. Sterne Jonathan A.C, Gavaghan David, Egger Matthias. Publication and related bias in meta-analysis: Power of statistical tests and prevalence in the literature. Journal of Clinical Epidemiology. 2000; 53: 1119-1129. PMID: 11106885
32. Egger M, Davey Smith G, Schneider M, Minder C. Bias in meta-analysis detected by a simple, graphical test. BMJ. 1997; 315: 629-634. PMID: 9310563
33. Gates MA, Vitonis AF, Tworoger SS, Rosner B, Titus-Ernstoff L, Hankinson SE, Cramer DW.Flavonoid intake and ovarian cancer risk in a population-based case-control study. Int J Cancer. 2009; 124:1918-1925. doi: 10.1002/ijc.24151 PMID: 19117058
34. Hedelin M, Löf M, Andersson TM, Adlercreutz H, Weiderpass E. Dietary phytoestrogens and the risk of ovarian cancer in the women's lifestyle and health cohort study. Cancer Epidemiol Biomarkers Prev. 2011; 20:308-317. doi: 10.1158/1055-9965.EPI-10-0752 PMID: 21098648
35. Wang L, Lee IM, Zhang SM, Blumberg JB, Buring JE, Sesso HD.Dietary intake of selected flavonols, flavones, and flavonoid-rich foods and risk of cancer in middle-aged and older women. Am J Clin Nutr. 2009; 89: 905-912. doi: 10.3945/ajcn.2008.26913 PMID: 19158208
36. Lee AH, Su D, Pasalich M, Tang L, Binns CW, Qiu L. Soy and isoflavone intake associated with reduced risk of ovarian cancer in southern Chinese women. Nutr Res. 2014; 34: 302-307. doi: 10.1016/j.nutres.2014.02.005 PMID: 24774066
37. Neill AS, Ibiebele TI, Lahmann PH, Hughes MC, Nagle CM, Webb PM; Australian Ovarian Cancer Study Group and Australian National Endometrial Cancer Study Group.Dietary phyto-oestrogens and the risk of ovarian and endometrial cancers: findings from two Australian case-control studies. Br J Nutr. 2014; 111: 1430-1440.
38. Bandera EV, King M, Chandran U, Paddock LE, Rodriguez-Rodriguez L, Olson SH. Phytoestrogen consumption from foods and supplements and epithelial ovarian cancer risk: a population-based case control study. BMC Womens Health. 2011; 11: 40. doi: 10.1186/1472-6874-11-40 PMID: 21943063
39. Kumar S, Pandey AK. Chemistry and biological activities of flavonoids: an overview. Scientific World Journal. 2013; 2013:162750. doi: 10.1155/2013/162750 PMID: 24470791
40. Hwang KA, Park MA, Kang NH, Yi BR, Hyun SH, Jeung EB, Choi KC. Anticancer effect of genistein on BG-1 ovarian cancer growth induced by 17 β-estradiol or bisphenol A via the suppression of the crosstalk between estrogen receptor a and insulin-like growth factor-1 receptor signaling pathways.Toxicol Appl Pharmacol. 2013; 272: 637-646. doi: 10.1016/j.taap.2013.07.027 PMID: 23933164
41. Kulbe H, Thompson R, Wilson JL, Robinson S, Hagemann T, Fatah R, Gould D, Ayhan A, Balkwill F. The inflammatory cytokine tumor necrosis factor-alpha generates an autocrine tumor-promoting network in epithelial ovarian cancer cells. Cancer Res. 2007; 67: 585-592. PMID: 17234767
42. Coward J, Kulbe H, Chakravarty P, Leader D, Vassileva V, Leinster DA, Thompson R, Schioppa T, Nemeth J, Vermeulen J, Singh N, Avril N, Cummings J, Rexhepaj E, Jirström K, Gallagher WM, Brennan DJ, McNeish IA, Balkwill FR. Interleukin-6 as a therapeutic target in human ovarian cancer. Clin Cancer Res. 2011; 17: 6083-6096. doi: 10.1158/1078-0432.CCR-11-0945 PMID: 21795409
43. Wang Y, Niu XL, Qu Y, Wu J, Zhu YQ, Sun WJ, Li LZ. Autocrine production of interleukin-6 confers cisplatin and paclitaxel resistance in ovarian cancer cells. Cancer Lett. 2010; 295: 110-123. doi: 10.1016/ j.canlet.2010.02.019 PMID: 20236757
44. Chen X, Anderson JJ. Isoflavones inhibit proliferation of ovarian cancer cells in vitro via an estrogen receptor-dependent pathway. Nutr Cancer. 2001; 41:165-171. PMID: 12094620
45. Hwang KA, Park MA, Kang NH, Yi BR, Hyun SH, Jeung EB, Choi KC. Anticancer effect of genistein on BG-1 ovarian cancer growth induced by 17 β-estradiol or bisphenol A via the suppression of the crosstalk between estrogen receptor a and insulin-like growth factor-1 receptor signaling pathways.Toxicol Appl Pharmacol. 2013; 272: 637-646. doi: 10.1016/j.taap.2013.07.027 PMID: 23933164
46. Kontopantelis E, Springate DA, Reeves D. A re-analysis of the Cochrane Library data: the dangers of unobserved heterogeneity in meta-analyses. PLoS One. 2013; 8: e69930. doi: 10.1371/journal.pone. 0069930 PMID: 23922860
47. Michal K, David A. S, Evangelos K. Publication bias in meta-analyses from the Cochrane Database of Systematic Reviews. Statist. Med. 2015; 34: 2781-2795.